Jefferies Financial Group Inc. operates as an investment banking and capital markets firm in the Americas, Europe, the Middle East, and the Asia-Pacific. The company operates in two segments, Investment Banking and Capital Markets, and Asset Management. It provides investment banking, advisory services with respect to mergers or acquisitions, debt financing, restructurings or recapitalizations, and private capital advisory transactions; underwriting and placement services related to corporate debt, municipal debts, mortgage-backed and asset-backed securities, equity and equity-linked securities, and loan syndication services; and corporate lending services. The company also offers financing, securities lending, and other prime brokerage services; equities research, sales, and trading services; wealth management services; and online foreign exchange trading services. In addition, it provides investment grade distressed debt securities, U.S. and European government and agency securities, municipal bonds, leveraged loans, emerging markets debt, and interest rate and credit index derivative products; and manages and offers services to a diverse group of alternative asset management platforms across a spectrum of investment strategies and asset classes. The company serves to public companies, private companies, and their sponsors and owners, institutional investors, and government entities. The company was formerly known as Leucadia National Corporation and changed its name to Jefferies Financial Group Inc. in May 2018. Jefferies Financial Group Inc. was founded in 1962 and is headquartered in New York, New York.

Jefferies Financial Group Inc.

DraftKings’ ($DKNG) shares edged higher during Thursday’s pre-market session. This followed the revelation that the online sports betting company i...

DraftKings (DKNG) Aims for 3M New Users in 2026, Bets on Prediction Market

On Tuesday, reports emerged that U.S. tech giant Meta ($META) is building its own prediction-market-style app called Arena to tap into the fast-gro...

Is Meta’s Prediction Market App a Threat to Flutter (FLUT)?

Definium Therapeutics stock was up after the company priced a new $700 million public offering.


Definium Therapeutics Stock (DFTX) Soars on a Public Offering Pricing After Strong Trial Results

Here’s a look at today’s key earnings reports from major publicly traded companies. Stock market investors will undoubtedly be watching closely for...

These Are the Stocks Reporting Earnings Today – June 24, 2026

On Wednesday, June 24, Micron ($MU), Jefferies ($JEF), and Paychex ($PAYX) will report their earnings. Paychex will report before the market open, ...

Polymarket Earnings: Will MU, JEF, PAYX Beat Earnings Tomorrow?

Jefferies ($JEF) analyst Philippe Houchois lowered his price target on Tesla stock ($TSLA) to $375, pointing to a potential drop of about 6% from r...

‘Merger Will Be Next,’ Says Jefferies Analyst as Tesla Stock Forecast Faces SpaceX Tracker Risk

Stocks ended the week higher as investors leaned back into risk assets, with technology leading the move. The Dow Jones Industrial Average (DJIA) r...

The Week That Was, The Week Ahead: Macro and Markets, June 21

Analysts are intrested in these 5 stocks: ( ($INTU) ), ( ($ALB) ), ( ($JEF) ), ( ($CME) ) and ( ($NICE) ). Here is a breakdown of their recent


Intuit, Albemarle, Jefferies, CME, NICE Trending With Analysts

The sector is getting a boost from AI data center demand. 


This Is the Best Utility Stock to Buy Now, Says Jefferies Financial Group (JEF)

New Jersey-based cardiovascular biotechnology company Kardigan is set to be valued at up to $1.4 billion in its upcoming U.S. IPO. Heart Disease Dr...

Heart-Disease Biotech Kardigan Set For $1.4B U.S. IPO

Beijer Ref AB Class B ( ($SE:BEIJ.B) ) has issued an update. Melker Schörling AB has agreed to acquire all outstanding A-shares in Beijer Ref from ...

MSAB Becomes Top Voting Shareholder in Beijer Ref in Long-Term Ownership Shift

In a report released today, Ryan Kenny from Morgan Stanley maintained a Hold rating on Jefferies, with a price target of $50.00. According to TipRa...

Jefferies (JEF) Receives a Hold from Morgan Stanley

Cloud provider Snowflake ($SNOW) is set to report earnings on May 27. Four-star Jefferies analyst Brent Thill stated, “We remain constructive on SN...

Current Quarter	$1.09	Next Quarter	$0.96
Current Year	$3.94	Next Year	$4.82
QoQ Growth	-11.9%	YoY Growth	+22.3%
3Y EPS CAGR	-2.2%	Target Price	$66.00
Consensus	Buy	Upside	+24.0%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	JEF	$53.22	-8.15%	3.04M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	JEF	$53.22	-8.1%	3.04M
3
4
5
6

JEF

JEF

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Jefferies Financial Group Inc. Data in Excel

Get Jefferies Financial Group Inc. Data in Excel